These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 33023061)

  • 1. Advances in D-Amino Acids in Neurological Research.
    Seckler JM; Lewis SJ
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia.
    Cheng YJ; Lin CH; Lane HY
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [About the NMDA-system again].
    Neuropsychopharmacol Hung; 2011 Mar; 13(1):2-3. PubMed ID: 21667571
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of D-Amino Acids in Alzheimer's Disease.
    Piubelli L; Murtas G; Rabattoni V; Pollegioni L
    J Alzheimers Dis; 2021; 80(2):475-492. PubMed ID: 33554911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
    Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
    J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective neuronal vulnerability and the distribution of N-methyl-D-aspartate (NMDA) receptors.
    Lee KS
    Neurobiol Aging; 1989; 10(5):609-11; discussion 618-20. PubMed ID: 2554170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer's disease.
    Hynd MR; Scott HL; Dodd PR
    J Neurochem; 2004 Aug; 90(4):913-9. PubMed ID: 15287897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-NMDA receptor-mediated neuronal injury in Alzheimer's disease?
    Choi DW
    Neurobiol Aging; 1989; 10(5):605-6; discussion 618-20. PubMed ID: 2554169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional decreases of free D-aspartate levels in Alzheimer's disease.
    D'Aniello A; Lee JM; Petrucelli L; Di Fiore MM
    Neurosci Lett; 1998 Jul; 250(2):131-4. PubMed ID: 9697936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.
    Dracheva S; Marras SA; Elhakem SL; Kramer FR; Davis KL; Haroutunian V
    Am J Psychiatry; 2001 Sep; 158(9):1400-10. PubMed ID: 11532724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia.
    Sakurai K; Toru M; Yamakawa-Kobayashi K; Arinami T
    Neurosci Lett; 2000 Dec; 296(2-3):168-70. PubMed ID: 11109007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are chimeric kainate/N-methyl-D-aspartate receptors expressed in Xenopus oocytes from mammalian and amphibian RNA?
    Brackley PT; Usherwood PN
    J Pharmacol Exp Ther; 1993 May; 265(2):910-9. PubMed ID: 7684447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
    Porter RH; Cowburn RF; Alasuzoff I; Briggs RS; Roberts PJ
    Eur J Pharmacol; 1992 Mar; 225(3):195-201. PubMed ID: 1387617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats.
    Löscher W; Hönack D; Fassbender CP
    Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
    Curras MC; Dingledine R
    Mol Pharmacol; 1992 Mar; 41(3):520-6. PubMed ID: 1372086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia.
    Errico F; Mothet JP; Usiello A
    J Pharm Biomed Anal; 2015 Dec; 116():7-17. PubMed ID: 25868730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of mRNAs encoding subunits of NMDA during postnatal development in rat inferior colliculus].
    Wan P; Lai XJ; Huang C
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 May; 18(2):189, 192. PubMed ID: 21179816
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of an UPLC-MS/MS method for simultaneous quantitation of 11 d-amino acids in different regions of rat brain: Application to a study on the associations of d-amino acid concentration changes and Alzheimer's disease.
    Li Z; Xing Y; Guo X; Cui Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1058():40-46. PubMed ID: 28531844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA
    Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.